Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF).
Xuan ZhangWen-Yao WangKuo ZhangJian TianJi-Lin ZhengJing ChenShi-Min AnSi-Yuan WangYu-Peng LiuYan ZhaoJing-Jia WangMin YangYi-Da TangPublished in: Trials (2019)
ClinicalTrials.gov, NCT03096613 . Registered on 30 March 2017.
Keyphrases
- open label
- phase iii
- heart failure
- phase ii
- clinical trial
- study protocol
- left ventricular
- high intensity
- phase ii study
- blood pressure
- double blind
- placebo controlled
- physical activity
- cardiac resynchronization therapy
- resistance training
- acute heart failure
- randomized controlled trial
- replacement therapy
- atrial fibrillation
- squamous cell carcinoma